GAAD

There are 4 papers on GAAD in aging research: 1 observational study in people, 2 reviews.

4 papers study it1 finding

See all 4 papers on GAAD

“GAAD slightly outperformed AFP (sensitivity: 76.2 %, specificity: 88.5 %).”

Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patientsAdvances in laboratory medicine2026doi:10.1515/almed-2025-0144

Humans1
In silico1

Associations

1

Hepatocellular carcinoma

upin humans1

1 study

GAAD predicts hepatocellular carcinoma in advanced liver fibrosis patients (sensitivity 76.2%, specificity 88.5%).
“GAAD slightly outperformed AFP (sensitivity: 76.2 %, specificity: 88.5 %).”
Humansin advanced liver fibrosis patients
Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patients
Advances in laboratory medicineJan 15, 2026

More on Hepatocellular carcinoma

Latest

4 papers in 12 months

Advances in Laboratory MedicineMar 19

Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patients

Cohort study of 30 peopleHepatocellular carcinoma

Journal of Medical EconomicsFeb 17

Cost-effectiveness of the GAAD algorithm for hepatocellular carcinoma surveillance of patients with compensated cirrhosis: a model-based analysis using Italian real-world data

Computational studyCirrhosis

Zhonghua Gan Zang Bing Za ZhiFeb 3

Expert consensus on the diagnosis, treatment, and management of liver nodules (version 2026)

ReviewBiomarkers

Liver CancerFeb 2

Utility of Biomarker Panels in the Surveillance and Monitoring of Hepatocellular Carcinoma: Consensus Statements from an International Delphi Panel

ReviewHepatocellular carcinoma